ES2032797T3 - Agente terapeutico para el tratamiento de la enfermedad ulcera peptica. - Google Patents

Agente terapeutico para el tratamiento de la enfermedad ulcera peptica.

Info

Publication number
ES2032797T3
ES2032797T3 ES198787114328T ES87114328T ES2032797T3 ES 2032797 T3 ES2032797 T3 ES 2032797T3 ES 198787114328 T ES198787114328 T ES 198787114328T ES 87114328 T ES87114328 T ES 87114328T ES 2032797 T3 ES2032797 T3 ES 2032797T3
Authority
ES
Spain
Prior art keywords
ulcera
treatment
therapeutic agent
peptica
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787114328T
Other languages
English (en)
Spanish (es)
Inventor
Masao Sakurai
Masayoshi Goto
Toshizo Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Application granted granted Critical
Publication of ES2032797T3 publication Critical patent/ES2032797T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES198787114328T 1986-10-06 1987-10-01 Agente terapeutico para el tratamiento de la enfermedad ulcera peptica. Expired - Lifetime ES2032797T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23607886 1986-10-06

Publications (1)

Publication Number Publication Date
ES2032797T3 true ES2032797T3 (es) 1993-03-01

Family

ID=16995393

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787114328T Expired - Lifetime ES2032797T3 (es) 1986-10-06 1987-10-01 Agente terapeutico para el tratamiento de la enfermedad ulcera peptica.

Country Status (16)

Country Link
US (1) US4845102A (enExample)
EP (1) EP0266559B1 (enExample)
JP (1) JPS63225317A (enExample)
KR (1) KR950007101B1 (enExample)
AT (1) ATE75399T1 (enExample)
AU (1) AU595379B2 (enExample)
CA (1) CA1297021C (enExample)
DE (1) DE3778642D1 (enExample)
DK (1) DK169305B1 (enExample)
ES (1) ES2032797T3 (enExample)
GR (1) GR3004848T3 (enExample)
HU (1) HU200098B (enExample)
IE (1) IE60863B1 (enExample)
IL (1) IL84096A (enExample)
PT (1) PT85866B (enExample)
ZA (1) ZA877454B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
DE4025371A1 (de) * 1990-08-10 1992-02-13 Kali & Salz Ag Verfahren zur reinigung von elektrostatisch gewonnenem steinsalz
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US5780476A (en) * 1992-11-16 1998-07-14 Cell Therapeutics, Inc. Hydroxyl-containing xanthine compounds
US6693105B1 (en) 1992-11-16 2004-02-17 Cell Therapeutics, Inc. Hydroxyl-containing compounds
US20030207901A1 (en) * 1999-07-27 2003-11-06 Cell Therapeutics, Inc. Hydroxyl-containing compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CH608236A5 (enExample) * 1974-01-22 1978-12-29 Wuelfing J A Fa
CA1075690A (en) * 1974-12-13 1980-04-15 Hoechst Aktiengesellschaft Xanthine derivatives
US4511557A (en) * 1981-08-24 1985-04-16 Gauri Kailash Kumar Pharmaceutical composition
IT1200944B (it) * 1982-08-10 1989-01-27 Malesci Sas Derivati xantinici,procedimento per la loro preparazione,composizione farmaceutiche che il contengono e loro impiego terapeutico
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement

Also Published As

Publication number Publication date
IE872656L (en) 1988-04-06
GR3004848T3 (enExample) 1993-04-28
US4845102A (en) 1989-07-04
IL84096A0 (en) 1988-03-31
KR950007101B1 (ko) 1995-06-30
AU595379B2 (en) 1990-03-29
DK520787D0 (da) 1987-10-05
DK520787A (da) 1988-04-07
HU200098B (en) 1990-04-28
JPS63225317A (ja) 1988-09-20
ATE75399T1 (de) 1992-05-15
EP0266559A2 (en) 1988-05-11
EP0266559B1 (en) 1992-04-29
AU7935887A (en) 1988-04-14
EP0266559A3 (en) 1990-06-06
DE3778642D1 (de) 1992-06-04
PT85866A (en) 1987-11-01
ZA877454B (en) 1988-05-25
DK169305B1 (da) 1994-10-10
IL84096A (en) 1991-07-18
HUT46214A (en) 1988-10-28
CA1297021C (en) 1992-03-10
IE60863B1 (en) 1994-08-24
PT85866B (pt) 1990-07-31
KR880004810A (ko) 1988-06-27

Similar Documents

Publication Publication Date Title
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
ES2032899T3 (es) Agente cosmetico para aplicacion externa y su uso.
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
ES2055745T3 (es) Compuestos antigestagenicos y antiestrogenos para el tratamiento de tumores hormono-dependientes.
AR003427A1 (es) Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas.
DE3774918D1 (de) Cancerostatisches mittel.
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK261490D0 (da) New pharmaceutical compound
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
ES2013796A6 (es) Agente cosmetico a base de derivados de pirimidina y retinoides, y procedimiento para prepararlo.
ES2032797T3 (es) Agente terapeutico para el tratamiento de la enfermedad ulcera peptica.
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
ES2036560T3 (es) Un metodo para preparar una composicion sinergicamente activa para el tratamiento de hipertension.
DK178188A (da) Antivirusmiddel
ES2039719T3 (es) Procedimiento para preparar un agente terapeutico para el tratamiento de la enfermedad de ulcera peptica.
ES2068942T3 (es) Derivados del acido butenoico.
ES2169124T3 (es) Acido 4-aminomicofenolico 6-sustituido y derivados con actividad inmunosupresora.
ATE18761T1 (de) Carbamoyloxybenzhydrol-derivate, ihre herstellung und ihre pharmazeutische zusammensetzungen.
ES2077698T3 (es) Agente terapeutico para la gangrena diabetica.
ES2094132T3 (es) Uso de derivados de xantina contra la ulcera peptica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 266559

Country of ref document: ES